Pironetin
(Synonyms: NK 10958, NL 9C, PA 48153c, (–)-Pironetin) 目录号 : GC38456An inhibitor of microtubule assembly
Cas No.:151519-02-7
Sample solution is provided at 25 µL, 10mM.
Pironetin is a bacterial metabolite originally isolated from Streptomyces that has diverse biological activities, including anti-proliferative, immunosuppressive, and plant growth regulatory properties.1,2,3,4 It binds to tubulin with a Kd value of 0.33 μM and increases the critical concentration (CrC) for tubulin assembly in glycerol-assembling buffer (GAB) at a concentration of 25 μM.2,3 It also induces G2/M phase cell cycle arrest in 3Y1 rat fibroblasts and apoptosis in HL-60 human leukemia cells when used at concentrations of 50 ng/ml and 33 nM, respectively.2,5 It inhibits the growth of HT-29 human colorectal and MCF-7 human breast cancer cells (IC50s = 6.4 and 6 nM, respectively) but also of non-cancerous human HEK293 cells (IC50 = 17 nM). It also inhibits the growth of A2780 human ovarian carcinoma cells, as well as of the drug-resistant, P-glycoprotein-expressing A2780AD subline (IC50s = 8 and 25 nM, respectively). Pironetin (5 mg/kg) decreases the generation of cytotoxic T lymphocytes in mice in response to immunization by EL4 allogeneic mouse T lymphocytes.4 It also inhibits rice plant growth by 23% when applied nine days prior to heading.1
1.Kobayashi, S., Tsuchiya, K., Harada, T., et al.Pironetin, a novel plant growth regulator produced by Streptomyces sp. NK10958. I. Taxonomy, production, isolation and preliminary characterizationJ. Antibiot. (Tokyo)47(6)697-702(1994) 2.Kondoh, M., Usui, T., Nishikiori, T., et al.Apoptosis induction via microtubule disassembly by an antitumour compound, pironetinBiochem. J.340(Pt 2)411-416(1999) 3.Vilanova, C., Díaz-Oltra, S., Murga, J., et al.Design and synthesis of pironetin analogue/colchicine hybrids and study of their cytotoxic activity and mechanisms of interaction with tubulinJ. Med. Chem.57(24)10391-10403(2014) 4.Yasui, K., Tamura, Y., Nakatani, T., et al.Chemical modification of PA-48153C, a novel immunosuppressant isolated from Streptomyces prunicolor PA-48153J. Antibiot. (Tokyo)49(2)173-180(1996) 5.Kondoh, M., Usui, T., Kobayashi, S., et al.Cell cycle arrest and antitumor activity of pironetin and its derivativesCancer Lett.126(1)29-32(1998)
Cas No. | 151519-02-7 | SDF | |
别名 | NK 10958, NL 9C, PA 48153c, (–)-Pironetin | ||
Canonical SMILES | O=C1C=C[C@H]([C@H](O1)C[C@H]([C@@H]([C@@H]([C@H](C/C=C/C)C)OC)C)O)CC | ||
分子式 | C19H32O4 | 分子量 | 324.45 |
溶解度 | Dichloromethane: soluble,DMSO: soluble,Ethanol: soluble | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.0821 mL | 15.4107 mL | 30.8214 mL |
5 mM | 0.6164 mL | 3.0821 mL | 6.1643 mL |
10 mM | 0.3082 mL | 1.5411 mL | 3.0821 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet